StockData

Jin Medical International Ltd. (ZJYL) company profile

ZJYLNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends September 30
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Sep 30, 2025Last filing: 20-F on Feb 10, 2026Score 3/30
$3.36−0.02 (-0.44%)

Close on Nov 18, 2026Market cap $526.00MP/E 16.8Yield –

About Jin Medical International

Orthopedic, Prosthetic & Surgical Appliances & Supplies, SIC 3842

Jin Medical International Ltd. is a holding company that develops and manufactures medical and technology products through its operating entities in the People's Republic of China. The company produces equipment and components across dedicated production facilities, while also expanding into newer product categories. It supplies these products through an established commercial network composed of independent distributors and dealers, serving commercial clients as well as a major primary customer that accounts for a significant portion of its sales volume.

The company operates primarily within mainland China, with operational subsidiaries and manufacturing infrastructure situated across Jiangsu Province, Changzhou City, and Shanghai. It sources materials from a specialized supplier base to support its domestic production capacity. Jin Medical International Ltd. is incorporated in the Cayman Islands and maintains its principal executive offices in Changzhou City, Jiangsu Province, People's Republic of China.

Summary of the business section of Jin Medical International's latest annual report, written by StockData.

Company profile

Company

Legal name
Jin Medical International Ltd.
Headquarters
Jiangsu Province, F4
Address
No. 33 Lingxiang Road, Wujin District, Changzhou City 213149
Phone
(86)51989607972
Employees
40, Sep 30, 2025
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Incorporated in
E9
Fiscal year ends
September 30
Auditor
Audit Alliance LLP, Singapore

Stock & identifiers

Ticker
ZJYL
Exchange
Nasdaq
IPO date
Mar 29, 2023
Shares outstanding
157M, Sep 30, 2025
Filer category
Non-accelerated filer<br>Emerging growth company
Stock splits
1-for-20 reverse, Aug 4, 2026; 1-for-20 reverse, Mar 16, 2026; 20-for-1, Feb 8, 2024
SEC CIK
1837821
CUSIP
G5140V120
FIGI
BBG012Q6SBJ7
Share class FIGI
BBG012Q6SCC2
EIN
00-0000000

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Ziqiang WangChief Financial Officer, Director–
Erqi WangChief Executive Officer, Director5,306,307
Ning XueDirector–
Oliver St Clair Franklin JrDirector–
James Jiayuan TongDirector–
Yanru GuoDirector–

IPO

From the final prospectus (Form 424B4) and the first day of trading

Offering

Type
Initial public offering
Final prospectus filed
Mar 29, 2023
Exchange
Nasdaq
First trading day
Mar 28, 2023
First-day close
$7.95
Lock-up ends (est.)
Sep 24, 2023

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

Employees

Headcount reported in annual reports

“has 40 employees as of the date of this report, many of whom own advanced degrees in engineering and related fields.”

Corporate history

Events identified from SEC filings

See a number that looks wrong?